Pages that link to "Q35782238"

The following pages link to Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. (Q35782238):

Displaying 32 items.

• Current status and prospect of lung cancer gene therapy (Q26825190) (← links)
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN (Q29619346) (← links)
• IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. (Q33670036) (← links)
• Cancer gene and immunotherapy: recent developments (Q33717186) (← links)
• Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8( ) cytotoxic T lymphocytes and CD4( ) T helper cells (Q33848587) (← links)
• Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy (Q33852789) (← links)
• Immunomodulation of cancer: potential use of selectively replicating agents (Q33904276) (← links)
• Therapeutic genes for cancer gene therapy (Q33996949) (← links)
• Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus (Q34328867) (← links)
• Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors. (Q35774179) (← links)
• Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer (Q36136052) (← links)
• Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells (Q36136494) (← links)
• Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma (Q36199032) (← links)
• Inhibition of tumor growth by elimination of granulocytes (Q36364220) (← links)
• Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma (Q36615915) (← links)
• Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder (Q36618832) (← links)
• The curious incident of 3 melanomas and their possible origins-A case report and review of literature (Q36866737) (← links)
• Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients (Q37127538) (← links)
• Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity (Q37357090) (← links)
• The polarization of immune cells in the tumour environment by TGFbeta (Q37454364) (← links)
• Cytokine-mediated gene therapy for cancer (Q40589441) (← links)
• Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. (Q40680221) (← links)
• Strategies for cytokine utilisation in tumor therapy. (Q40789606) (← links)
• Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials? (Q40932118) (← links)
• New therapeutic approaches based on gene transfer techniques (Q41202952) (← links)
• Immunotherapy I: Cyclosine gene transfer strategies (Q41349062) (← links)
• Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions (Q41349081) (← links)
• Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta (Q41365438) (← links)
• Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma (Q41546511) (← links)
• Interferon gamma-independent rejection of interleukin 12-transduced carcinoma cells requires CD4 T cells and Granulocyte/Macrophage colony-stimulating factor (Q41886939) (← links)
• FMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils. (Q42033770) (← links)
• Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically (Q42389372) (← links)